Search
Now showing items 1-10 of 10
Ventricular conduction and long-term heart failure outcomes and mortality in African Americans: insights from the Jackson Heart Study.
(Circ Heart Fail, 2015-03)
BACKGROUND: QRS prolongation is associated with adverse outcomes in mostly white populations,
but its clinical significance is not well established for other groups. We investigated
the association between QRS duration and ...
Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
(J Am Heart Assoc, 2015-05-21)
BACKGROUND: The characteristics of patients undergoing atrial fibrillation (AF) ablation
and subsequent outcomes in community practice are not well described. METHODS AND
RESULTS: Using the Outcomes Registry for Better Informed ...
Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.
(J Cardiovasc Pharmacol, 2015-05)
Furosemide has historically been the primary loop diuretic in heart failure patients
despite data suggesting potential advantages with torsemide. We used the Duke Echocardiography
Lab Database to investigate patients admitted ...
Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).
(Circ Heart Fail, 2015-07)
BACKGROUND: Congestion is the most frequent cause for hospitalization in acute decompensated
heart failure. Although decongestion is a major goal of acute therapy, it is unclear
how the clinical components of congestion ...
Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?
(J Am Heart Assoc, 2015-08-03)
Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke.
(J Am Heart Assoc, 2015-07-22)
BACKGROUND: Timely thrombolytic therapy can improve stroke outcomes. Nevertheless,
the ability of US hospitals to meet guidelines for intravenous tissue plasminogen
activator (tPA) remains suboptimal. What is unclear is ...
Contemporary trends and predictors of postacute service use and routine discharge home after stroke.
(J Am Heart Assoc, 2015-02-23)
BACKGROUND: Returning home after the hospital is a primary aim for healthcare; however,
additional postacute care (PAC) services are sometimes necessary for returning stroke
patients to their pre-event status. Recent trends ...
Relationship Between Cancer and Cardiovascular Outcomes Following Percutaneous Coronary Intervention.
(J Am Heart Assoc, 2015-07-06)
BACKGROUND: Cardiovascular disease and cancer increasingly coexist, yet relationships
between cancer and long-term cardiovascular outcomes post-percutaneous coronary intervention
(PCI) are not well studied. METHODS AND RESULTS: ...
Platelet aggregation and mental stress induced myocardial ischemia: Results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study.
(Am Heart J, 2015-04)
BACKGROUND: Mental stress-induced myocardial ischemia (MSIMI) is common in patients
with ischemic heart disease (IHD) and associated with a poorer cardiovascular prognosis.
Platelet hyperactivity is an important factor in ...
Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study.
(BMJ (Clinical research ed.), 2015-07-31)
To examine the association between warfarin treatment and longitudinal outcomes after
ischemic stroke in patients with atrial fibrillation in community practice.Observational
study.Hospitals (n = 1487) participating in the ...